Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 147 articles:
HTML format



Single Articles


    January 2022
  1. MEIJER TS, Dieters JHN, de Leede EM, de Geus-Oei LF, et al
    Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    PLoS One. 2022;17:e0261939.
    PubMed     Abstract available


  2. SHIRAISHI T, Tominaga T, Nonaka T, Hashimoto S, et al
    Effect of hemodialysis on short-term outcomes after colon cancer surgery.
    PLoS One. 2022;17:e0262531.
    PubMed     Abstract available


    January 2021
  3. CHEN L, Alexanderson KAE
    Trajectories of sickness absence and disability pension before and after colorectal cancer: A Swedish longitudinal population-based matched cohort study.
    PLoS One. 2021;16:e0245246.
    PubMed     Abstract available


  4. KOCH J, Monch D, Maass A, Gromoll C, et al
    Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines.
    PLoS One. 2021;16:e0244513.
    PubMed     Abstract available


  5. KNAPP GC, Alatise O, Olopade B, Samson M, et al
    Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria.
    PLoS One. 2021;16:e0243587.
    PubMed     Abstract available


  6. KLEPININA L, Klepinin A, Truu L, Chekulayev V, et al
    Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network.
    PLoS One. 2021;16:e0245348.
    PubMed     Abstract available


  7. FARUK M, Ibrahim S, Aminu SM, Adamu A, et al
    Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
    PLoS One. 2021;16:e0245581.
    PubMed     Abstract available


  8. MIYAZAKI Y, Nakamura T, Takenouchi S, Hayashi A, et al
    Urinary 8-iso PGF2alpha and 2,3-dinor-8-iso PGF2alpha can be indexes of colitis-associated colorectal cancer in mice.
    PLoS One. 2021;16:e0245292.
    PubMed     Abstract available


  9. ETISSA EK, Assefa M, Ayele BT
    Prognosis of colorectal cancer in Tikur Anbessa Specialized Hospital, the only oncology center in Ethiopia.
    PLoS One. 2021;16:e0246424.
    PubMed     Abstract available


  10. OHIRA H, Tsuruya A, Oikawa D, Nakagawa W, et al
    Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration: Implications for the pathogenesis of ethanol-related colorectal cancer.
    PLoS One. 2021;16:e0246580.
    PubMed     Abstract available


  11. SHINOZAKI E, Makiyama A, Kagawa Y, Satake H, et al
    Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.
    PLoS One. 2021;16:e0246160.
    PubMed     Abstract available


  12. VUNDAVILLI H, Datta A, Sima C, Hua J, et al
    Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
    PLoS One. 2021;16:e0247190.
    PubMed     Abstract available


  13. KOBAYASHI Y, Kumamoto K, Okayama H, Matsumoto T, et al
    Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer.
    PLoS One. 2021;16:e0247169.
    PubMed     Abstract available


  14. USHER-SMITH JA, Mills KM, Riedinger C, Saunders CL, et al
    The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment.
    PLoS One. 2021;16:e0246991.
    PubMed     Abstract available


  15. YE P, Cai P, Xie J, Wei Y, et al
    The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248775.
    PubMed     Abstract available


  16. TAUBE M, Peltonen M, Sjoholm K, Palmqvist R, et al
    Long-term incidence of colorectal cancer after bariatric surgery or usual care in the Swedish Obese Subjects study.
    PLoS One. 2021;16:e0248550.
    PubMed     Abstract available


  17. EL AGY F, El Bardai S, El Otmani I, Benbrahim Z, et al
    Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.
    PLoS One. 2021;16:e0248522.
    PubMed     Abstract available


  18. GREENWOOD A, Keating J, Kenwright D, Shekouh A, et al
    Brief report: Lymph node morphology in stage II colorectal cancer.
    PLoS One. 2021;16:e0249197.
    PubMed     Abstract available


  19. YUEN HF, McCrudden CM, Huang YH, Tham JM, et al
    Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer.
    PLoS One. 2021;16:e0250187.
    PubMed     Abstract available


  20. HAN KT, Kim S
    Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
    PLoS One. 2021;16:e0250716.
    PubMed     Abstract available


  21. AL-RAJAB M, Lu J, Xu Q
    A framework model using multifilter feature selection to enhance colon cancer classification.
    PLoS One. 2021;16:e0249094.
    PubMed     Abstract available


  22. CAINAP C, Ungur RA, Bochis OV, Achimas P, et al
    Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis.
    PLoS One. 2021;16:e0248922.
    PubMed     Abstract available


  23. DE'ANGELIS N, Baldini C, Brustia R, Pessaux P, et al
    Correction: Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251005.
    PubMed     Abstract available


  24. ALHARBI A, Bin Dokhi H, Almuhaini G, Alomran F, et al
    Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.
    PLoS One. 2021;16:e0249590.
    PubMed     Abstract available


  25. HONDA M, Naoe H, Gushima R, Miyamoto H, et al
    Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.
    PLoS One. 2021;16:e0245211.
    PubMed     Abstract available


  26. GUO Y, Guo Y, Luo Y, Song X, et al
    Comparison of pathologic outcomes of robotic and open resections for rectal cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245154.
    PubMed     Abstract available


  27. HELMER RA, Martinez-Zaguilan R, Kaur G, Smith LA, et al
    Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis.
    PLoS One. 2021;16:e0251132.
    PubMed     Abstract available


  28. ABDALLA TSA, Meiners J, Riethdorf S, Konig A, et al
    Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
    PLoS One. 2021;16:e0252897.
    PubMed     Abstract available


  29. KIM HG, Yang SY, Han YD, Cho MS, et al
    Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer.
    PLoS One. 2021;16:e0252566.
    PubMed     Abstract available


  30. LIM TZ, Lau J, Wong GJ, Tan KK, et al
    Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study from a public tertiary hospital.
    PLoS One. 2021;16:e0250460.
    PubMed     Abstract available


  31. JIN J, Chen B, Zhan X, Zhou Z, et al
    Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang.
    PLoS One. 2021;16:e0252508.
    PubMed     Abstract available


  32. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    PubMed     Abstract available


  33. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available


  34. VIVES N, Farre A, Ibanez-Sanz G, Vidal C, et al
    Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
    PLoS One. 2021;16:e0245806.
    PubMed     Abstract available


  35. DAI YC, Fang CY, Yang HY, Jian YJ, et al
    The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.
    PLoS One. 2021;16:e0254000.
    PubMed     Abstract available


  36. CHAI L, Ni J, Ni X, Zhang N, et al
    Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population.
    PLoS One. 2021;16:e0253474.
    PubMed     Abstract available


  37. IBANEZ-SANZ G, Mila N, Vidal C, Rocamora J, et al
    Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    PLoS One. 2021;16:e0253369.
    PubMed     Abstract available


  38. SPAANDERMAN IT, Peters FS, Jongejan A, Redeker EJW, et al
    Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
    PLoS One. 2021;16:e0251630.
    PubMed     Abstract available


  39. KHARIN L, Bychkov I, Karnaukhov N, Voloshin M, et al
    Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
    PLoS One. 2021;16:e0252132.
    PubMed     Abstract available


  40. VANACLOCHA-ESPI M, Ibanez J, Molina-Barcelo A, Valverde-Roig MJ, et al
    Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.
    PLoS One. 2021;16:e0254021.
    PubMed     Abstract available


  41. WANG E, Shibutani M, Nagahara H, Fukuoka T, et al
    Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.
    PLoS One. 2021;16:e0255049.
    PubMed     Abstract available


  42. VECCHIOTTI G, Colafarina S, Aloisi M, Zarivi O, et al
    Genotoxicity and oxidative stress induction by polystyrene nanoparticles in the colorectal cancer cell line HCT116.
    PLoS One. 2021;16:e0255120.
    PubMed     Abstract available


  43. HEID-PICARD B, Cochand-Priollet B, Rozenberg F, Giang-Phang D, et al
    Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method.
    PLoS One. 2021;16:e0246338.
    PubMed     Abstract available


  44. HIDALGO-TENORIO C, Garcia-Martinez CM, Pasquau J, Omar-Mohamed-Balgahata M, et al
    Risk factors for >/=high-grade anal intraepithelial lesions in MSM living with HIV and the response to topical and surgical treatments.
    PLoS One. 2021;16:e0245870.
    PubMed     Abstract available


  45. LEE Y, Lee JA, Park HE, Han H, et al
    Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas.
    PLoS One. 2021;16:e0246356.
    PubMed     Abstract available


  46. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.
    PLoS One. 2021;16:e0244898.
    PubMed     Abstract available


  47. ZHANG Z, Jia H, Wang Y, Du B, et al
    Association of MACC1 expression with lymphatic metastasis in colorectal cancer: A nested case-control study.
    PLoS One. 2021;16:e0255489.
    PubMed     Abstract available


  48. WINITCHAIKUL T, Sawong S, Surangkul D, Srikummool M, et al
    Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells.
    PLoS One. 2021;16:e0254392.
    PubMed     Abstract available


  49. SUSKO MS, Lazar AA, Wang CJ, Van Loon K, et al
    Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer.
    PLoS One. 2021;16:e0246535.
    PubMed     Abstract available


  50. SHI W, Li X, Su X, Wen H, et al
    The role of multiple metabolic genes in predicting the overall survival of colorectal cancer: A study based on TCGA and GEO databases.
    PLoS One. 2021;16:e0251323.
    PubMed     Abstract available


  51. LEE K, Seo H, Choe S, Jeong SY, et al
    Intentions to undergo primary screening with colonoscopy under the National Cancer Screening Program in Korea.
    PLoS One. 2021;16:e0247252.
    PubMed     Abstract available


  52. SAUNDERS AS, Bender DE, Ray AL, Wu X, et al
    Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
    PLoS One. 2021;16:e0247233.
    PubMed     Abstract available


  53. HAMEED Y, Usman M, Liang S, Ejaz S, et al
    Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
    PLoS One. 2021;16:e0256020.
    PubMed     Abstract available


  54. PRAKASH MD, Stojanovska L, Feehan J, Nurgali K, et al
    Anti-cancer effects of polyphenol-rich sugarcane extract.
    PLoS One. 2021;16:e0247492.
    PubMed     Abstract available


  55. KESKIN H, Wang SM, Etemadi A, Fan JH, et al
    Colorectal cancer in the Linxian China Nutrition Intervention Trial: Risk factors and intervention results.
    PLoS One. 2021;16:e0255322.
    PubMed     Abstract available


  56. GAFNI A, Dite GS, Spaeth Tuff E, Allman R, et al
    Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank.
    PLoS One. 2021;16:e0251469.
    PubMed     Abstract available


  57. ISHIKAWA M, Takashima A, Nagata Y, Sawada R, et al
    Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study.
    PLoS One. 2021;16:e0257551.
    PubMed     Abstract available


  58. CONTURSI A, Arconzo M, Cariello M, Piglionica M, et al
    let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects.
    PLoS One. 2021;16:e0249238.
    PubMed     Abstract available


  59. OGAWA M, Urano M, Takaishi T, Kan H, et al
    T-staging of rectal cancer: Utility of single-shot turbo spin-echo diffusion-weighted imaging with T2-weighted images and fusion images.
    PLoS One. 2021;16:e0249433.
    PubMed     Abstract available



  60. Correction: Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    PLoS One. 2021;16:e0258077.
    PubMed     Abstract available


  61. RODRIGUEZ-TOMAS E, Arenas M, Gomez J, Acosta J, et al
    Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
    PLoS One. 2021;16:e0250453.
    PubMed     Abstract available


  62. SUN Q, Pastor L, Du J, Powell MJ, et al
    A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
    PLoS One. 2021;16:e0244332.
    PubMed     Abstract available


  63. O'SHEA R, Taylor N, Crook A, Jacobs C, et al
    Health system interventions to integrate genetic testing in routine oncology services: A systematic review.
    PLoS One. 2021;16:e0250379.
    PubMed     Abstract available


  64. YAMANO T, Kubo S, Sonoda E, Kominato T, et al
    Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
    PLoS One. 2021;16:e0250072.
    PubMed     Abstract available


  65. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
    Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
    PLoS One. 2021;16:e0250426.
    PubMed     Abstract available


  66. EL BIZRI M, El Sheikh M, Lee GE, Sewitch MJ, et al
    Mobile health technologies supporting colonoscopy preparation: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0248679.
    PubMed     Abstract available


  67. MORIMOTO M, Taniguchi K, Yamamoto O, Naka T, et al
    Preoperative white blood cell count predicts anastomotic leakage in patients with left-sided colorectal cancer.
    PLoS One. 2021;16:e0258713.
    PubMed     Abstract available


  68. SHIRAKAMI Y, Nakanishi T, Ozawa N, Ideta T, et al
    Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
    PLoS One. 2021;16:e0251942.
    PubMed     Abstract available


  69. CHEN S, Wang Y, Wang B, Zhang L, et al
    A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    PLoS One. 2021;16:e0258741.
    PubMed     Abstract available



  70. Expression of Concern: A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
    PLoS One. 2021;16:e0259176.
    PubMed    


  71. KOBORI T, Tameishi M, Tanaka C, Urashima Y, et al
    Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.
    PLoS One. 2021;16:e0250889.
    PubMed     Abstract available


  72. BOWLER-BARNETT E, Martinez-Garcia FD, Sherwood M, Aleidan A, et al
    Proteomic characterization of GSK3beta knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
    PLoS One. 2021;16:e0246707.
    PubMed     Abstract available


  73. CHEN YC, Tsai HL, Li CC, Huang CW, et al
    Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.
    PLoS One. 2021;16:e0259460.
    PubMed     Abstract available


  74. TRUELSEN SLB, Mousavi N, Wei H, Harvey L, et al
    The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
    PLoS One. 2021;16:e0253258.
    PubMed     Abstract available


  75. BULUT G, Guner Oytun M, Almuradova E, Harman M, et al
    Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis.
    PLoS One. 2021;16:e0259622.
    PubMed     Abstract available


  76. EZENKWA US, Okolo CA, Ogun GO, Akere A, et al
    Cyclooxygenase-2 expression in colorectal carcinoma, adenomatous polyps and non-tumour bearing margins of resection tissues in a cohort of black Africans.
    PLoS One. 2021;16:e0255235.
    PubMed     Abstract available


  77. ORABI KY, Abaza MS, Luqmani YA, Al-Attiyah R, et al
    Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways.
    PLoS One. 2021;16:e0252820.
    PubMed     Abstract available


  78. TAKASU C, Yamashita S, Morine Y, Yoshikawa K, et al
    The role of the immunoescape in colorectal cancer liver metastasis.
    PLoS One. 2021;16:e0259940.
    PubMed     Abstract available


  79. CHAIWONGKOT A, Phanuphak N, Pankam T, Bhattarakosol P, et al
    Human papillomavirus 16 L1 gene methylation as a potential biomarker for predicting anal intraepithelial neoplasia in men who have sex with men (MSM).
    PLoS One. 2021;16:e0256852.
    PubMed     Abstract available


  80. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
    Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
    PLoS One. 2021;16:e0253893.
    PubMed     Abstract available


  81. KOO K, Ward R, Smith RL, Ruben J, et al
    Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
    PLoS One. 2021;16:e0254018.
    PubMed     Abstract available


  82. SARGENTI A, Musmeci F, Cavallo C, Mazzeschi M, et al
    A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib.
    PLoS One. 2021;16:e0252907.
    PubMed     Abstract available


  83. SOMMARIVA S, Scussolini M, Cossu V, Marini C, et al
    The role of endoplasmic reticulum in in vivo cancer FDG kinetics.
    PLoS One. 2021;16:e0252422.
    PubMed     Abstract available


  84. WANG T, Fei J, Nie S
    Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
    PLoS One. 2021;16:e0260035.
    PubMed     Abstract available


  85. SYED SOFFIAN SS, Safian N, Nawi AM, Ahmad SB, et al
    Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
    PLoS One. 2021;16:e0258129.
    PubMed     Abstract available


  86. BENEDEK Z, Surjan C, Belicza E
    Potential considerations in decision making on laparoscopic colorectal resections in Hungary based on administrative data.
    PLoS One. 2021;16:e0257811.
    PubMed     Abstract available


  87. PARK J, Han JS, Jo HJ, Kim HY, et al
    Resting heart rate is associated with colorectal advanced adenoma.
    PLoS One. 2021;16:e0254505.
    PubMed     Abstract available


  88. GOLDSBURY DE, Feletto E, Weber MF, Haywood P, et al
    Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
    PLoS One. 2021;16:e0260088.
    PubMed     Abstract available


  89. CHENG YW, Li YC
    Factors affecting the follow-up time after a positive result in the fecal occult blood test.
    PLoS One. 2021;16:e0258130.
    PubMed     Abstract available


  90. HEIL TC, Melis RJF, Maas HAAM, van Munster BC, et al
    Technical efficiency evaluation of colorectal cancer care for older patients in Dutch hospitals.
    PLoS One. 2021;16:e0260870.
    PubMed     Abstract available


  91. PERNE C, Peters S, Cartolano M, Horpaopan S, et al
    Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis.
    PLoS One. 2021;16:e0259185.
    PubMed     Abstract available


  92. FIGUEIREDO JC, Passarelli MN, Wei W, Ahnen DJ, et al
    Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.
    PLoS One. 2021;16:e0258878.
    PubMed     Abstract available


  93. WALCHECK MT, Matkowskyj KA, Turco A, Blaine-Sauer S, et al
    Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
    PLoS One. 2021;16:e0259245.
    PubMed     Abstract available


  94. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
    Clinical correlates of circulating cell-free DNA tumor fraction.
    PLoS One. 2021;16:e0256436.
    PubMed     Abstract available


  95. MUNRO MJ, Peng L, Wickremesekera SK, Tan ST, et al
    Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors.
    PLoS One. 2021;16:e0256280.
    PubMed     Abstract available


  96. LI K, Fathan MI, Patel K, Zhang T, et al
    Colonoscopy polyp detection and classification: Dataset creation and comparative evaluations.
    PLoS One. 2021;16:e0255809.
    PubMed     Abstract available


  97. POURNOOR E, Mousavian Z, Nowzari-Dalini A, Masoudi-Nejad A, et al
    A propagation-based seed-centric local community detection for multilayer environment: The case study of colon adenocarcinoma.
    PLoS One. 2021;16:e0255718.
    PubMed     Abstract available


  98. MOHAMMED M, Mboya IB, Mwambi H, Elbashir MK, et al
    Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data.
    PLoS One. 2021;16:e0261625.
    PubMed     Abstract available


  99. DAEMEN A, Udyavar AR, Sandmann T, Li C, et al
    Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
    PLoS One. 2021;16:e0262198.
    PubMed     Abstract available


  100. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
    Genome-wide host methylation profiling of anal and cervical carcinoma.
    PLoS One. 2021;16:e0260857.
    PubMed     Abstract available


  101. ASTARITA JL, Keerthivasan S, Husain B, Senbabaoglu Y, et al
    The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.
    PLoS One. 2021;16:e0260800.
    PubMed     Abstract available


  102. ELZINGA J, van der Lugt B, Belzer C, Steegenga WT, et al
    Characterization of increased mucus production of HT29-MTX-E12 cells grown under Semi-Wet interface with Mechanical Stimulation.
    PLoS One. 2021;16:e0261191.
    PubMed     Abstract available


    January 2020
  103. MIYAMOTO Y, Schirripa M, Suenaga M, Cao S, et al
    A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
    PLoS One. 2020;15:e0239439.
    PubMed     Abstract available


  104. HILSDEN RJ, Maxwell CM, Forbes N, Bridges RJ, et al
    Development of a definition and rules for causal attribution of post-colonoscopy bleeding.
    PLoS One. 2020;15:e0235902.
    PubMed     Abstract available


  105. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    PubMed     Abstract available


  106. KARABACHEV AD, Martini DJ, Hermel DJ, Solcz D, et al
    Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
    PLoS One. 2020;15:e0233673.
    PubMed     Abstract available


  107. KOI M, Okita Y, Takeda K, Koeppe ES, et al
    Co-morbid risk factors and NSAID use among white and black Americans that predicts overall survival from diagnosed colon cancer.
    PLoS One. 2020;15:e0239676.
    PubMed     Abstract available


  108. TAKASU C, Nishi M, Yoshikawa K, Tokunaga T, et al
    Impact of sidedness of colorectal cancer on tumor immunity.
    PLoS One. 2020;15:e0240408.
    PubMed     Abstract available


  109. CAI H, Zhang Y, Liu X, Jiang W, et al
    Association of age and cause-special mortality in patients with stage I/ II colon cancer: A population-based competing risk analysis.
    PLoS One. 2020;15:e0240715.
    PubMed     Abstract available


  110. KING LE, Zhang HH, Gould CM, Thomas DW, et al
    Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen.
    PLoS One. 2020;15:e0240746.
    PubMed     Abstract available


  111. MASON SE, Scott AJ, Markar SR, Clarke JM, et al
    Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic.
    PLoS One. 2020;15:e0240397.
    PubMed     Abstract available


  112. MATTHES N, Diers J, Schlegel N, Hankir M, et al
    Validation of MTL30 as a quality indicator for colorectal surgery.
    PLoS One. 2020;15:e0238473.
    PubMed     Abstract available


  113. ZHANG T, Ahn K, Emerick B, Modarai SR, et al
    APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
    PLoS One. 2020;15:e0239601.
    PubMed     Abstract available


  114. HALE LP
    Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis.
    PLoS One. 2020;15:e0239295.
    PubMed     Abstract available


  115. NOH GT, Kwon J, Kim J, Park M, et al
    Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines.
    PLoS One. 2020;15:e0242057.
    PubMed     Abstract available


  116. GABEL P, Larsen MB, Edwards A, Kirkegaard P, et al
    Effectiveness of a decision aid for colorectal cancer screening on components of informed choice according to educational attainment: A randomised controlled trial.
    PLoS One. 2020;15:e0241703.
    PubMed     Abstract available


  117. ASADOLLAHI P, Ghanavati R, Rohani M, Razavi S, et al
    Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0242387.
    PubMed     Abstract available


  118. WANG Y, Xie G, Li M, Du J, et al
    COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.
    PLoS One. 2020;15:e0240106.
    PubMed     Abstract available


  119. HOLM M, Andersson E, Osterlund E, Ovissi A, et al
    Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.
    PLoS One. 2020;15:e0239819.
    PubMed     Abstract available


  120. SILVA KA, Duarte AX, Cruz AR, de Araujo LB, et al
    Time after ostomy surgery and type of treatment are associated with quality of life changes in colorectal cancer patients with colostomy.
    PLoS One. 2020;15:e0239201.
    PubMed     Abstract available


  121. MALAGON M, Ramio-Pujol S, Serrano M, Amoedo J, et al
    New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
    PLoS One. 2020;15:e0243158.
    PubMed     Abstract available


  122. SHARMA A, Vatapalli R, Abdelfatah E, McMahon KW, et al
    Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
    PLoS One. 2020;15:e0242750.
    PubMed     Abstract available


  123. WANG Y, Liu Y, Han G, Yi B, et al
    The severity of postoperative complications after robotic versus laparoscopic surgery for rectal cancer: A systematic review, meta-analysis and meta-regression.
    PLoS One. 2020;15:e0239909.
    PubMed     Abstract available


  124. JO P, Bernhardt M, Nietert M, Konig A, et al
    KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
    PLoS One. 2020;15:e0239806.
    PubMed     Abstract available



  125. Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.
    PLoS One. 2020;15:e0244268.
    PubMed    



  126. Retraction: Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer.
    PLoS One. 2020;15:e0244280.
    PubMed    


  127. ARNADOTTIR SS, Mattesen TB, Vang S, Madsen MR, et al
    Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    PLoS One. 2020;15:e0241148.
    PubMed     Abstract available


  128. ANDREU-BALLESTER JC, Galindo-Regal L, Hidalgo-Coloma J, Cuellar C, et al
    Differences in circulating gammadelta T cells in patients with primary colon cancer and relation with prognostic factors.
    PLoS One. 2020;15:e0243545.
    PubMed     Abstract available


  129. LUO P, Wu S, Ji K, Yuan X, et al
    LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.
    PLoS One. 2020;15:e0223035.
    PubMed     Abstract available


  130. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    PubMed     Abstract available


  131. HARDCASTLE SJ, Jimenez-Castuera R, Maxwell-Smith C, Bulsara MK, et al
    Fitbit wear-time and patterns of activity in cancer survivors throughout a physical activity intervention and follow-up: Exploratory analysis from a randomised controlled trial.
    PLoS One. 2020;15:e0240967.
    PubMed     Abstract available


  132. HUANG CW, Su WC, Yin TC, Chen PJ, et al
    Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy.
    PLoS One. 2020;15:e0240742.
    PubMed     Abstract available


  133. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    PubMed     Abstract available


  134. HONG TC, Yang HC, Chen CL, Kao JH, et al
    Relationship between serum gamma-glutamyl transferase level and colorectal adenoma.
    PLoS One. 2020;15:e0240445.
    PubMed     Abstract available


  135. MINEUR L, Francois E, Plassot C, Phelip JM, et al
    PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.
    PLoS One. 2020;15:e0243997.
    PubMed     Abstract available


  136. LIANG X, Hendryx M, Qi L, Lane D, et al
    Association between prediagnosis depression and mortality among postmenopausal women with colorectal cancer.
    PLoS One. 2020;15:e0244728.
    PubMed     Abstract available


  137. PISCITELLO A, Saoud L, Fendrick AM, Borah BJ, et al
    Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model.
    PLoS One. 2020;15:e0244431.
    PubMed     Abstract available


  138. SHIRASUNA K, Ito M, Matsuda T, Enomoto T, et al
    Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients.
    PLoS One. 2020;15:e0243643.
    PubMed     Abstract available


  139. DARBA J, Marsa A
    Evaluation of productivity losses due to premature mortality from colorectal cancer.
    PLoS One. 2020;15:e0244375.
    PubMed     Abstract available


  140. FLYNN DE, Mao D, Yerkovich ST, Franz R, et al
    The impact of comorbidities on post-operative complications following colorectal cancer surgery.
    PLoS One. 2020;15:e0243995.
    PubMed     Abstract available


  141. GRANATA V, Fusco R, Avallone A, Cassata A, et al
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
    PLoS One. 2020;15:e0241431.
    PubMed     Abstract available


  142. MARTIN-GONZALEZ P, de Mariscal EG, Martino ME, Gordaliza PM, et al
    Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study.
    PLoS One. 2020;15:e0242597.
    PubMed     Abstract available


  143. KING BH, Baumgartner JM, Kelly KJ, Marmor RA, et al
    Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    PLoS One. 2020;15:e0243252.
    PubMed     Abstract available


  144. SAKAMOTO J, Ozawa H, Nakanishi H, Fujita S, et al
    Oncologic outcomes after resection of para-aortic lymph node metastasis in left-sided colon and rectal cancer.
    PLoS One. 2020;15:e0241815.
    PubMed     Abstract available


  145. WEISSINGER M, Vogel J, Kupferschlager J, Dittmann H, et al
    Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
    PLoS One. 2020;15:e0244235.
    PubMed     Abstract available


  146. BORTOLAMI M, Comparato A, Benna C, Errico A, et al
    Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    PLoS One. 2020;15:e0244356.
    PubMed     Abstract available


  147. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: